Effects of Fucoidan on Nitric Oxide Production and Activator Protein-1 Activation in Lipopolysaccharide-Stimulated Porcine Peripheral Blood Mononuclear Cells

다국어 초록 (Multilingual Abstract)

Fucoidan which is sulfated polysaccharide extracted from brown seaweed has a wide variety of internal biological activities. The objectives of this study were to examine the effect of fucoidan on nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated porcine peripheral blood mononuclear cells (PBMCs) and to investigate whether this effect is involved in the expression of inducible nitric oxide synthase (iNOS) and the activation of activator portein- 1 (AP-1). The levels of NO production and AP-1 activity in the culture supernatants from porcine PBMCs were measured by the enzyme-linked immunosorbent assay and the levels of iNOS and AP-1 mRNA were determined by real time polymerase chain reaction. Fucoidan in LPS-naïve PBMCs has no effects on the production of NO and activity of AP-1. Expressions of iNOS and AP-1 mRNA in LPS-naïve PBMCs were also not affected by treatment of fucoidan.
However, NO production, AP-1 activity and expressions of iNOS and AP-1 mRNA were dramatically increased in PBMCs stimulated with LPS. Enhancing effects of NO production and AP-1 activity in PBMCs induced by LPS were reduced by addition of fucoidan. Fucoidan also inhibited an increase in expressions of iNOS and AP-1 mRNA in LPS-stimulated PBMCs. These results suggested that fucoidan exerts anti-inflammatory effect by down-regulating production of NO via suppressing expression of iNOS and activity of AP-1 in LPS-stimulated porcine PBMCs.

참고문헌 (Reference)

1 Kim DI, "Trans-10, cis-12-conjugated linoleic acid modulates NF-κB activation and TNF-α production in porcine peripheral blood mononuclear cells via a PPARγ-dependent pathway" 105 : 1329-1336, 2011

2 Noman AS, "Thalidomide inhibits lipopolysaccharide-induced nitric oxide production and prevents lipopolysaccharide-mediated lethality in mice" 56 : 204-211, 2009

3 Kwon DJ, "Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7macrophages" 58 : 479-486, 2013

4 Iwakiri Y, "Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages" 67 : 435-443, 2002

5 Baba M, "Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus" 32 : 1742-1745, 1988

6 Berteau O, "Sulfated fucans, fresh perspectives:structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide" 13 : 29-40, 2003

7 Bilan MI, "Structure of a fucoidan from the brown seaweed Fucus evanescens C.Ag" 337 : 719-730, 2002

8 Nathan C, "Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens" 97 : 8841-8848, 2000

9 Murphy S, "Production of nitric oxide by glial cells: regulation and potential roles in the CNS" 29 : 1-13, 2000

10 Sorensen NS, "Porcine blood mononuclear cell cytokine responses to PAMP molecules : comparison of mRNA and protein production" 139 : 296-302, 2011

11 Irhimeh MR, "Pilot clinical study to evaluate the anticoagulant activity of fucoidan" 20 : 607-610, 2009

12 Koyanagi S, "Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities" 65 : 173-179, 2003

13 Sarkar FH, "NF-κB signaling pathway and its therapeutic implications in human diseases" 27 : 293-319, 2008

14 Mankan AK, "NF-κB regulation: the nuclear response" 13 : 631-643, 2009

15 Block ML, "Microglia-mediated neurotoxicity:uncovering the molecular mechanisms" 8 : 57-69, 2007

16 Dauphinee SM, "Lipopolysaccharide signaling in endothelial cells" 86 : 9-22, 2005

17 Cui YQ, "Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia" 37 : 422-428, 2010

18 Chen YC, "Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages" 82 : 537-548, 2001

19 Pampusch MS, "Inducible nitric oxide synthase expression in porcine immune cells" 61 : 279-289, 1998

20 Kröncke KD, "Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities" 376 : 327-343, 1995

21 Yokota T, "Increased effect of fucoidan on lipoprotein lipase secretion in adipocytes" 84 : 523-529, 2009

22 Nakamura T, "Fucoidan induces nitric oxide production via p38 mitogenactivated protein kinase and NF-κB-dependent signaling pathways through macrophage scavenger receptors" 343 : 286-294, 2006

23 Li B, "Fucoidan : structure and bioactivity" 13 : 1671-1695, 2008

24 Feng GJ, "Extracellular signal-related kinase(ERK)and p38 mitogen-activated protein(MAP)kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages : Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase" 163 : 6403-6412, 1999

25 Bäckström L, "Effect of atrophic rhinitis on growth rate in Illinois swine herds" 187 : 712-715, 1985

26 Choi RJ, "Desoxyrhapontigenin, a potent anti-inflammatory phytochemical, inhibits LPSinduced inflammatory responses via suppressing NF-κB and MAPK pathways in RAW 264.7 cells." 18 : 182-190, 2014

27 Kikuchi T, "Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors" 49 : 745-755, 2002

28 Ohshima H, "Chronic infections and inflammatory processes as cancer risk factors : possible role of nitric oxide in carcinogenesis" 305 : 253-264, 1994

29 Shan J, "Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264. 7 cells through suppressing NF-κB and JNK/AP-1 activation" 9 : 1042-1048, 2009

30 Yang JW, "Bifunctional effect of fucoidan on the expression of inducible nitric oxide synthase" 346 : 345-350, 2006

31 DeGroote MA, "Antimicrobial properties of nitric oxide. In: Nitric oxide and infection" Kluwer Academic Publishers 231-261, 2002

32 Park HY, "Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells" 49 : 1745-1752, 2011

33 Chun J, "Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells" 14 : 375-383, 2012

34 Shaulian E, "AP-1 in cell proliferation and survival" 20 : 2390-2400, 2001

35 Cumashi A, "A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds" 17 : 541-552, 2007